Prostate Cancer - Results from #26640

Relationship between PSA kinetics and [(18)F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy - Abstract December 13, 2011

A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese population - Abstract December 13, 2011

East meets West: Ethnic differences in prostate cancer epidemiology between East Asians and Caucasians - Abstract December 13, 2011

Editor's Commentary - Late gastrointestinal toxicities following radiation therapy for prostate cancer December 13, 2011

Panel endorses active monitoring and delay of treatment for low-risk prostate cancer December 13, 2011

Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation - Abstract December 12, 2011

Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment - Abstract December 12, 2011

Robotic-assisted laparoscopic prostatectomy for high-risk prostate cancer: Technical considerations and review of the literature - Abstract December 12, 2011

Cancer risk and behavioral factors, comorbidities, and functional status in the US elderly population - Abstract December 12, 2011

Cytotoxic activity of peripheral blood mononuclear leukocytes, activated by interleukin-2/β-cyclodextrin nanocomposition against androgen receptor-negative prostate cancers - Abstract December 12, 2011

Management options in advanced prostate cancer: What is the role for sipuleucel-T - Abstract December 12, 2011

Integration of regulatory networks by NKX3.1 promotes androgen-dependent prostate cancer survival - Abstract December 12, 2011

Comparison of template-matching and singular-spectrum-analysis methods for imaging implanted brachytherapy seeds - Abstract December 12, 2011

Novel vitamin D analogs for prostate cancer therapy - Abstract December 12, 2011

Biochemical control with radiotherapy improves overall survival in intermediate and high-risk prostate cancer patients who have an estimated 10-year overall survival of >90% - Abstract December 9, 2011

Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer - Abstract December 9, 2011

The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells - Abstract December 9, 2011

Risk prediction for prostate cancer recurrence through regularized estimation with simultaneous adjustment for nonlinear clinical effects - Abstract December 9, 2011

Does pharmacological castration as adjuvant therapy for prostate cancer after radiotherapy affect anxiety and depression levels, cognitive functions and quality of life - Abstract December 9, 2011

New ultrasound technologies for the diagnostics of prostate cancer - Abstract December 9, 2011

Page 1333 of 1436